BOSTON--(BUSINESS WIRE)-- #bpgbio--BPGbio to present novel E2-based targeted protein degradation program at TPD and Induced Proximity Summit in Boston.
BPGbio is a Massachusetts-based clinical-stage biopharmaceutical company that offers solutions such as disease mapping and data analytics for the healthcare sector.